Max Bylesjo
8Patents
2h-index
23Co-inventors
43Inventor score
Filing activity: Sep 15, 2011 → Feb 7, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10196691B2 | Colon cancer gene expression signatures and methods of use | Chemistry; Metallurgy | 60 | Active |
| US10260097B2 | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent | Physics | 7 | Active |
| US10214777B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 1 | Active |
| US10378066B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 0 | Active |
| US11091809B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 0 | Active |
| US11254986B2 | Gene signature for immune therapies in cancer | Chemistry; Metallurgy | 0 | Active |
| US9670547B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 0 | Active |
| US9677140B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.